Medicine composition of imipenem-cilastatin-tazobactam
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 深圳麦德凯诺医药科技有限公司
- Publication Date
- 2012-12-05
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention provides a combination medicine, in particular, a combination medicine of imipenem cilastatin sodium / tazobactam sodium for treating infectious diseases caused by Acinetobacter baumannii. It belongs to the field of medical technology. Background technique
[0002] Carbapenem antibiotics are a class of antibiotics with the broadest antibacterial spectrum and strong antibacterial activity so far. In the past 20 years, imipenem and cilastatin sodium among carbapenems have been used as compound preparations. Its components are imipenem 500mg and cilastatin sodium (calculated as C16H25N2O5S) 500mg, which are key drugs for the treatment of severe infections, especially in the treatment of severe infections of the respiratory tract, which have irreplaceable curative effects and have saved the lives of countless patients , but with the widespread use of carbapenems, the resistance rate of Acinetobacter baumannii to carbapenems has increased year ...